Difficult reversal of dabigatran with idarucizumab in a multiple-trauma patient: A question of dose?

Dabigatran is an oral anticoagulant directly acting as thrombin inhibitor. The monoclonal antibody idarucizumab was developed to reverse its anticoagulatory effects after application of a standardized dose. Following administration, dabigatran plasma level rebounds have been reported but its consequ...

Full description

Bibliographic Details

Published in:	Trauma case reports Vol. 32; p. 100422
Main Authors:	Ströhle, Mathias, Rugg, Christopher, Schmid, Stefan, Fries, Dietmar, Oswald, Elgar
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Ltd 01-04-2021 Elsevier
Subjects:	Antidote Bleeding Case Report Dabigatran Idarucizumab Multiple trauma Multiple trauma Dabigatran Antidote Idarucizumab Bleeding
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!